Pjsm. Kerstens et al., AZATHIOPRINE-RELATED BONE-MARROW TOXICITY AND LOW ACTIVITIES OF PURINE ENZYMES IN PATIENTS WITH RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 38(1), 1995, pp. 142-145
Objective. Azathioprine (AZA) metabolism largely parallels the endogen
ous purine pathways. To date, thiopurine methyltransferase (TPMT) defi
ciency has been reported as a cause of AZA-related bone marrow toxicit
y in 1 patient with rheumatoid arthritis (RA). We therefore studied pu
rine enzyme activities in 3 patients with RA who experienced AZA-relat
ed bone marrow toxicity. Methods. Lymphocyte activity of purine nucleo
side phosphorylase and 5'-nucleotidase (5NT) and erythrocyte activity
of TPMT, key enzymes in thiopurine catabolism, were measured in 3 RA p
atients who had experienced AZA-related bone marrow toxicity and in 16
RA patients without signs of toxicity despite at least 6 months of tr
eatment with AZA. Results. Two patients with AZA-related home marrow t
oxicity were found to have a TPMT deficiency, 1 partial and 1 total. I
n the third patient, 5NT activity was found to be well below the lowes
t level observed in the control subjects. Conclusion. All 3 patients w
ith severe AZA-related bone marrow toxicity had abnormal purine enzyme
activities. Deficiency of purine enzymes, including TPMT and 5NT, may
be a cause of AZA-related bone marrow toxicity in patients with RA.